HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
Pratibha C. Koneru(University of Colorado Anschutz Medical Campus), Mamuka Kvaratskhelia(The Ohio State University), Michael F. Wempe(Eastman Chemical Company (United States)), Ronald M. Levy(Temple University), Ashley C. Hoyte(University of Colorado Anschutz Medical Campus), Daniel Adu‐Ampratwum(The Ohio State University), Alan Engelman(Harvard University), Ashwanth C. Francis(Emory University), Jared Lindenberger(University of Colorado Anschutz Medical Campus), Dmitry Lyumkis(Salk Institute for Biological Studies), James R. Fuchs(The Ohio State University), Nanjie Deng(Pace University), Ross C. Larue(The Ohio State University), Gregory B. Melikyan(Emory University), Stephanie Rebensburg(The Ohio State University)
Cited by 50
Related Papers
Addressing preferred specimen orientation in single-particle cryo-EM through tilting
|Nature Methods|2017|1k
Appion: An integrated, database-driven pipeline to facilitate EM image processing
|Journal of Structural Biology|2009|960
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|Science|2013|826
The structural biology of HIV-1: mechanistic and therapeutic insights
|Nature Reviews Microbiology|2012|395